Replay available

Aspen Aerogels, Inc. (ASPN) Q2 2025 Earnings Call

Aspen Aerogels, Inc. (NYSE: ASPN) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.

Thu, August 7, 2025 at 8:30 AMendedReplay
Aspen Aerogels, Inc. (ASPN) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Neil Berenowsky

Senior Director, Head of Investor Relations and Corporate Strategy

Don Young

President and CEO

Ricardo Rodriguez

Chief Financial Officer and Treasurer

Eric Stein

Analyst, Craig Hallam

Colin Roosh

Analyst, Oppenheimer

Ryan Finxt

Analyst, V. Riley

David Anderson

Analyst, Barclays

Ittea Mikali

Analyst, TD Cowan

Leanne Hayden

Analyst, Canaccord Genuity

Tom Curran

Analyst, Seaport Research Partners

Replay transcript excerpt

Good morning. Thank you for attending the Aspen AeroGels Incorporated Q2 2025 Financial Results Call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. I would now like to turn the conference over to your host, Neil Berenowsky, Aspen's Senior Director, Head of Investor Relations and Corporate Strategy. Thank you. You may proceed, Mr. Berenowsky. Thank you, Megan. Good morning and thank you for joining us for the Aspen AeroGels Second Quarter 2025 Financial Results Conference Call. With us today are Don Young, President and CEO, and Ricardo Rodriguez, Chief Financial Officer and Treasurer. The press release announcing Aspen's financial results and business developments and the slide deck that will accompany our conversation today are available on the Investors section of Aspen's website, .aerogel.com. During this call, we will refer to non-GAAP financial measures, including adjusted EBITDA and adjusted net income. The reconciliations between GAAP and non-GAAP measures are included in the back of the slide presentation and earnings release. On today's call, management will make forward-looking statements about our expectations. These statements are subjects to risks and uncertainties that could cause our actual results to differ materially. These risks and uncertainties include the factors identified in our filings with the SEC. Please review the disclaimer statements on page one of the slide deck as the content of our call will be governed by this language. I'd also like to note that from time to time, in connection with the vesting of restricted stock units and or stock options issued under our long-term equity incentive program, we expect that our Section 16 officers will file Forms 4 to rep...

More from Aspen Aerogels, Inc.